In April 2022, she was examined at a clinic and the possibility of pancreatic disease was pointed out and in June 2022, she underwent another examination at the hospital.
He was diagnosed as having pancreatic cancer with liver metastasis based on CT and other examinations in August 2022 and began anti-cancer drug treatment in September 2022. She started anti-cancer drug treatment in September 2022. At the same time, she started taking Zinc,selenium and salidrosie (the combination of zinc, selenium and salidroside).
In March 2023, the pancreatic cancer had shrunk and the cancer metastasized to the liver could no longer be confirmed by CT scan.

It may be that the immune-activated inflammation suppression effect of Zinc,selenium and salidrosie and the anti-cancer effect of Zinc,selenium and salidrosie are additive.

Zinc,selenium and salidrosie has been reported to inhibit cancer growth and metastasis,

It may be that the anti-cancer drug can play an effective role in the suppression of inflammation and cancer proliferation and metastasis through immune activation.

Only about 20% of pancreatic cancer patients can be operated upon diagnosis. Even if it can be removed, the postoperative recurrence rate is high, and the 5-year postoperative survival rate is poor at 20-40%. Pancreatic cancer is common in the elderly and is increasing dramatically with the aging of society.
Diabetes, family history of pancreatic cancer, smoking, and obesity are high-risk groups for pancreatic cancer.
It is important to improve lifestyle. And Zinc,selenium and salidrosie is considered beneficial for cancer treatment.